Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
FEMALE
ID03496636

Autologous Ovarian Tissue Transplantation for Female Infertility After Chemotherapy or Radiation

Led by University of Pittsburgh · Updated on 2025-08-14

5

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to study the safety and effectiveness of using a woman's own previously frozen ovarian tissue to help restore fertility in females diagnosed with primary ovarian insufficiency after chemotherapy and/or radiation treatments. The study is designed to evaluate how well ovarian tissue transplantation can improve reproductive hormone levels and support pregnancy in women who have experienced infertility due to cancer treatments. The treatment involves thawing and surgically transplanting ovarian cortical tissue that was previously frozen. This is done through minimally invasive surgery such as laparoscopy or a small abdominal incision if laparoscopy is not suitable. After transplantation, patients will have scheduled follow-up visits to monitor their recovery, hormone levels, menstrual function, and possible pregnancy outcomes. The study also includes an annual survey starting three years after transplantation to gather longer-term information. Participants will undergo a screening visit with fertility tests, hormone measurements, ultrasound exams, and counseling, including clearance from their oncologist. After transplantation, follow-up visits occur at 1.5, 3, 6, 9, 12, and 24 months to assess reproductive health and quality of life using hormone tests, ultrasounds, and validated surveys. Safety monitoring includes checking for surgical complications and possible cancer recurrence. The study may continue tracking participants for up to 15 years with yearly surveys to record menstrual cycles, pregnancy, and health status.

CONDITIONS

Brief Title

Autologous Ovarian Tissue Transplantation

Who Can Participate

Age: 18Years - 45Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Previously cryopreserved ovarian tissue
  • Diagnosis of ovarian insufficiency and/or candidate for pregnancy
  • Good overall health
  • Clearance from oncologist to participate
Not Eligible

You will not qualify if you...

  • High risk for surgical complications
  • Contraindication for pregnancy if pregnancy is a goal
  • Positive for BRCA gene mutations
  • History of leukemia, ovarian cancer, or cancer involving ovaries at tissue collection
  • Psychological or psychiatric conditions preventing informed consent
  • Current pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Single day procedure with immediate recovery period

Participants undergo ovarian tissue thawing and transplantation via outpatient laparoscopy or minilaparotomy under general anesthesia.

1 pre-operative visit and 1 transplantation visit (in-person)

Post-operative Follow-up

Duration - Up to 24 months post-transplant

Participants have a series of assessments during the first two years after transplantation to monitor reproductive hormone levels, menstrual function, surgical complications, pregnancy status, and emotional well-being.

Approximately 7 visits: 1 post-operative visit within 6 weeks and 5 follow-up visits at 3, 6, 9, 12, and 24 months post-op, plus additional visits if menstruation is restored between scheduled visits (all in-person)

Long-term Monitoring

Duration - Annual surveys beginning year 3 post-transplant

Participants are surveyed annually starting 3 years after transplantation to track menstrual and pregnancy history, new diagnoses or treatments, and study participation experience.

Annual surveys via phone or secure email

Trial Site Locations

Total: 1 location

1

Magee-Womens Hospital

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

Loading map...

Research Team

J

Jennifer Anglin

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Phase I Clinical Trial to Compare the Pharmacokinetics, Sa...

Assisted Reproductive Technology

Actively Recruiting

1 location

Clinical Application of Autologous Adipose Stem Mitochondria...

Female Infertility

Actively Recruiting

1 location

Letrozole Alone vs. Letrozole Plus Levothyroxine for Ovulati...

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here